Latest news from Wardray Premise

Launch of new TetraGraph Neuromuscular Monitoring System

23 February 2018

The TetraGraph allows physicians to monitor the effects of neuromuscular blocking drugs perioperatively.

The TetraGraph neuromuscular monitor is a unique system designed to address the needs of perioperative monitoring of physiologic data in surgical patients receiving general anesthesia and muscle relaxation using neuromuscular blocking drugs (NMBAs).

The TetraGraph stimulates a peripheral nerve and measures, analyzes and displays the muscle function in surgical patients who receive NMBAs as part of their general anesthetic.

Wardray Premise Ltd are delighted to be appointed as Senzime’s UK distributor for the TetraGraph.

If you would like further information please contact Ian Benton, email ibenton@wardray-premise.com telephone 0208 3989911.

Other Press Releases By This Company

Released By

Wardray Premise

Related Websites

Related Categories

Related Industry Sectors